Identification of a Phosphatidic Acid-Preferring Phospholipase Al
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Elimination of GPI2 Suppresses Glycosylphosphatidylinositol Glcnac
bioRxiv preprint doi: https://doi.org/10.1101/2021.03.18.436003; this version posted March 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Elimination of GPI2 suppresses glycosylphosphatidylinositol GlcNAc transferase activity and alters GPI glycan modification in Trypanosoma brucei Aurelio Jenni‡§, SeBastian Knüsel¶, Rupa Nagar||, Mattias Benninger¶, RoBert Häner**, Michael A. J. Ferguson||, IsaBel Roditi¶, Anant K. Menon#, Peter Bütikofer‡1 From the ‡Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland, the §Graduate School for Chemical and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland, the ¶Institute of Cell Biology, University of Bern, 3012 Bern, Switzerland, the ||Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee, United Kingdom, the **Department for Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland, the #Department of Biochemistry, Weill Cornell Medical College, New York, New York 10065, USA. Running Title: GPI synthesis in the absence of GPI2 * The work was supported By Swiss National Science Foundation Sinergia grant CRSII5_170923 to RH, AKM and PB, by a Wellcome Tust Investigator Award (101842/Z13/Z) to MAJF and Swiss National Science Foundation grant 310030_184669 to IR. The authors declare that they have no conflicts of interest with the contents of this article. 1 To whom correspondence should Be addressed: Institute of Biochemistry and Molecular Medicine, Bühlstrasse 28, 3012 Bern, Switzerland. Tel.: 41-31-631-4113; E-mail: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.18.436003; this version posted March 19, 2021. -
Suramin Alters Phosphoinositide Synthesis and Inhibits Growth Factor Receptor Binding in HT-29 Cells'
(CANCER RESEARCH 50. 6490-6496. October 15. 1990] Suramin Alters Phosphoinositide Synthesis and Inhibits Growth Factor Receptor Binding in HT-29 Cells' Reinhard Kopp2 and Andreas Pfeiffer Departments of Surgery and Internal Medicine II, Klinikum (irosshadern. University of Munich, West Germany ABSTRACT levels and a stimulation of calcium/calmodulin kinases. Di acylglycerol activates protein kinase C, a family of Ca2+-sensi- Initiation of cell growth frequently involves activation of growth factor tive and phospholipid-dependent isoenzymes, known to phos- receptor-coupled u rosine kinases and stimulation of the phosphoinositide phorylate regulatory proteins and to elevate cytosolic pH levels second messenger system. The antitrypanosomal and antifiliarial drug suramin has been shown to exert antiproliferative activities by inhibition (5, 6). Activation of protein kinase C by phorbol esters and of growth factor receptor binding. We therefore investigated the effect of elevation of intracellular calcium levels by calcium ionophores suramin on epidermal growth factor receptor-binding characteristics and, have been shown to be mitogenically active cofactors during the additionally, searched for effects on basal or cholinergically stimulated initiation of DNA synthesis (7-10). phospholipid metabolism in HT-29 cells. HT-29 colon carcinoma cells have recently been shown to Suramin caused a dose-dependent and noncompetitive inhibition of produce EGF/transforming growth factor «and insulin-like '"I-epidermal growth factor binding (concentration producing 50% inhi growth factor 1-like activities (11), indicating a possible auto bition, 44.2 Mg/ml)but did not alter muscarinic receptor binding. Suramin did not affect the basal '-'I* incorporation into phosphoinositides at crine proliferative effect of these growth factors. -
(4,5) Bisphosphate-Phospholipase C Resynthesis Cycle: Pitps Bridge the ER-PM GAP
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UCL Discovery Topological organisation of the phosphatidylinositol (4,5) bisphosphate-phospholipase C resynthesis cycle: PITPs bridge the ER-PM GAP Shamshad Cockcroft and Padinjat Raghu* Dept. of Neuroscience, Physiology and Pharmacology, Division of Biosciences, University College London, London WC1E 6JJ, UK; *National Centre for Biological Sciences, TIFR-GKVK Campus, Bellary Road, Bangalore 560065, India Address correspondence to: Shamshad Cockcroft, University College London UK; Phone: 0044-20-7679-6259; Email: [email protected] Abstract Phospholipase C (PLC) is a receptor-regulated enzyme that hydrolyses phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) at the plasma membrane (PM) triggering three biochemical consequences, the generation of soluble inositol 1,4,5-trisphosphate (IP3), membrane– associated diacylglycerol (DG) and the consumption of plasma membrane PI(4,5)P2. Each of these three signals triggers multiple molecular processes impacting key cellular properties. The activation of PLC also triggers a sequence of biochemical reactions, collectively referred to as the PI(4,5)P2 cycle that culminates in the resynthesis of this lipid. The biochemical intermediates of this cycle and the enzymes that mediate these reactions are topologically distributed across two membrane compartments, the PM and the endoplasmic reticulum (ER). At the plasma membrane, the DG formed during PLC activation is rapidly converted to phosphatidic acid (PA) that needs to be transported to the ER where the machinery for its conversion into PI is localised. Conversely, PI from the ER needs to be rapidly transferred to the plasma membrane where it can be phosphorylated by lipid kinases to regenerate PI(4,5)P2. -
Role of Phospholipases in Adrenal Steroidogenesis
229 1 W B BOLLAG Phospholipases in adrenal 229:1 R29–R41 Review steroidogenesis Role of phospholipases in adrenal steroidogenesis Wendy B Bollag Correspondence should be addressed Charlie Norwood VA Medical Center, One Freedom Way, Augusta, GA, USA to W B Bollag Department of Physiology, Medical College of Georgia, Augusta University (formerly Georgia Regents Email University), Augusta, GA, USA [email protected] Abstract Phospholipases are lipid-metabolizing enzymes that hydrolyze phospholipids. In some Key Words cases, their activity results in remodeling of lipids and/or allows the synthesis of other f adrenal cortex lipids. In other cases, however, and of interest to the topic of adrenal steroidogenesis, f angiotensin phospholipases produce second messengers that modify the function of a cell. In this f intracellular signaling review, the enzymatic reactions, products, and effectors of three phospholipases, f phospholipids phospholipase C, phospholipase D, and phospholipase A2, are discussed. Although f signal transduction much data have been obtained concerning the role of phospholipases C and D in regulating adrenal steroid hormone production, there are still many gaps in our knowledge. Furthermore, little is known about the involvement of phospholipase A2, Endocrinology perhaps, in part, because this enzyme comprises a large family of related enzymes of that are differentially regulated and with different functions. This review presents the evidence supporting the role of each of these phospholipases in steroidogenesis in the Journal Journal of Endocrinology adrenal cortex. (2016) 229, R1–R13 Introduction associated GTP-binding protein exchanges a bound GDP for a GTP. The G protein with GTP bound can then Phospholipids serve a structural function in the cell in that activate the enzyme, phospholipase C (PLC), that cleaves they form the lipid bilayer that maintains cell integrity. -
Synthesis of Lysophospholipids
Molecules 2010, 15, 1354-1377; doi:10.3390/molecules15031354 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Synthesis of Lysophospholipids Paola D’Arrigo 1,2,* and Stefano Servi 1,2 1 Dipartimento di Chimica, Materiali ed Ingegneria Chimica “Giulio Natta”, Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy 2 Centro Interuniversitario di Ricerca in Biotecnologie Proteiche "The Protein Factory", Politecnico di Milano and Università degli Studi dell'Insubria, Via Mancinelli 7, 20131 Milano, Italy * Author to whom correspondence should be addressed; E-Mail: paola.d’[email protected]. Received: 17 February 2010; in revised form: 4 March 2010 / Accepted: 5 March 2010 / Published: 8 March 2010 Abstract: New synthetic methods for the preparation of biologically active phospholipids and lysophospholipids (LPLs) are very important in solving problems of membrane–chemistry and biochemistry. Traditionally considered just as second-messenger molecules regulating intracellular signalling pathways, LPLs have recently shown to be involved in many physiological and pathological processes such as inflammation, reproduction, angiogenesis, tumorogenesis, atherosclerosis and nervous system regulation. Elucidation of the mechanistic details involved in the enzymological, cell-biological and membrane-biophysical roles of LPLs relies obviously on the availability of structurally diverse compounds. A variety of chemical and enzymatic routes have been reported in the literature for the synthesis of LPLs: the enzymatic transformation of natural glycerophospholipids (GPLs) using regiospecific enzymes such as phospholipases A1 (PLA1), A2 (PLA2) phospholipase D (PLD) and different lipases, the coupling of enzymatic processes with chemical transformations, the complete chemical synthesis of LPLs starting from glycerol or derivatives. In this review, chemo- enzymatic procedures leading to 1- and 2-LPLs will be described. -
Antibody Response Cell Antigen Receptor Signaling And
Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response This information is current as Jiancheng Hu, Shannon K. Oda, Kristin Shotts, Erin E. of September 24, 2021. Donovan, Pamela Strauch, Lindsey M. Pujanauski, Francisco Victorino, Amin Al-Shami, Yuko Fujiwara, Gabor Tigyi, Tamas Oravecz, Roberta Pelanda and Raul M. Torres J Immunol 2014; 193:85-95; Prepublished online 2 June 2014; Downloaded from doi: 10.4049/jimmunol.1300429 http://www.jimmunol.org/content/193/1/85 Supplementary http://www.jimmunol.org/content/suppl/2014/05/31/jimmunol.130042 http://www.jimmunol.org/ Material 9.DCSupplemental References This article cites 63 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/193/1/85.full#ref-list-1 Why The JI? Submit online. by guest on September 24, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response Jiancheng Hu,*,1,2 Shannon K. -
Activation by Inhibition of Second Messenger Compounds
1230 Annals ofthe Rheumatic Diseases 1992; 51: 1230-1236 Sulphasalazine inhibition of human granulocyte Ann Rheum Dis: first published as 10.1136/ard.51.11.1230 on 1 November 1992. Downloaded from activation by inhibition of second messenger compounds Gunnar Carlin, Richard Djursater, Goran Smedegard Abstract We have previously found by using the The effects of sulphasalazine on the pro- granulocyte as a model system that sulpha- duction of second messenger compounds in salazine inhibits cellular activation before activa- human granulocytes have been characterised tion of protein kinase C by interference with the by various stimuli. The increases in cytosolic synthesis of phosphoinositide derived second calcium, inositol trisphosphate, diacylgly- messenger compounds.6 As several cell types cerol, and phosphatidic acid (all important utilise phosphoinositide dependent signal trans- mediators of intracellular signal transduction) duction, sulphasalazine may modify a principal triggered by stimulation were inhibited by common mechanism for the regulation of sulphasalazine. The metabolites 5-amino- cell activity, which may explain the beneficial salicylic acid and sulphapyridine were less effects of the drug in a variety of diseases. potent inhibitors than the mother compound. Many of the stimuli used in the earlier studies It is concluded that sulphasalazine inhibits trigger an increase in cytosolic calcium as part of the synthesis of phosphoinositide derived the activation sequence. The increase in calcium second messenger compounds at the level of has, in a variety of cell systems, been found to phospholipase C or its regulatory guanosine depend on remodelling of phosphoinositides'3 5'-triphosphate (GTP) binding protein. In- (see fig 1). Ligation of a cell receptor leads to hibition of phosphatidic acid synthesis was the phospholipase C dependent hydrolysis of either due to the same mechanism, or to phosphatidylinositol-4,5-bisphosphate genera- interaction with a phospholipase D regulating ting two triggers of cell responses, namely GTP binding protein. -
G-Proteins in Growth and Apoptosis: Lessons from the Heart
Oncogene (2001) 20, 1626 ± 1634 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc G-proteins in growth and apoptosis: lessons from the heart John W Adams1,2 and Joan Heller Brown*,1 1University of California, San Diego, Department of Pharmacology, 9500 Gilman Drive, 0636, La Jolla, CA, California 92093- 0636, USA The acute contractile function of the heart is controlled by for proliferation of adult cardiomyocytes. In light of the eects of released nonepinephrine (NE) on cardiac these considerations, it is not immediately obvious that adrenergic receptors. NE can also act in a more chronic cardiomyocyte growth and cardiomyocyte death would fashion to induce cardiomyocyte growth, characterized by be responses critical to the normal function of the heart. cell enlargement (hypertrophy), increased protein synth- In fact, the ability of cardiomyocytes to undergo esis, alterations in gene expression and addition of hypertrophic growth, which includes an increase in cell sarcomeres. These responses enhance cardiomyocyte size, is an important adaptive response to a wide range of contractile function and thus allow the heart to conditions that require the heart to work more compensate for increased stress. The hypertrophic eects eectively. As described below, adaptive or compensa- of NE are mediated through Gq-coupled a1-adrenergic tory cardiomyocyte hypertrophy appears to be regulated receptors and are mimicked by the actions of other in large part through stimulation of G-protein coupled neurohormones (endothelin, prostaglandin F2a angiotensin receptors (GPCRs). Often, the ability of cardiomyocytes II) that also act on Gq-coupled receptors. Activation of to function at high capacity under increased workload phospholipase C by Gq is necessary for these responses, cannot be sustained and the heart transitions into a and protein kinase C and MAP kinases have also been condition in which ventricular failure develops. -
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
0031-6997/02/5402-265–269$7.00 PHARMACOLOGICAL REVIEWS Vol. 54, No. 2 Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics 20204/989285 Pharmacol Rev 54:265–269, 2002 Printed in U.S.A International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature JEROLD CHUN, EDWARD J. GOETZL, TIMOTHY HLA, YASUYUKI IGARASHI, KEVIN R. LYNCH, WOUTER MOOLENAAR, SUSAN PYNE, AND GABOR TIGYI Merck Research Laboratories, La Jolla, California (J.C.); Department of Medicine, University of California, San Francisco, California (E.J.G.); Department of Physiology, University of Connecticut, Farmington, Connecticut (T.L.H.); Department of Biomembrane and Biofunctional Chemisty, Hokkaido University, Sapporo, Japan (Y.I.); Department of Pharmacology, University of Virginia, Charlottesville, Virginia (K.R.L.); Division of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands (W.M.); Department of Physiology and Pharmacology, University of Strathclyde, Glasgow, Scotland (S.P.); and Department of Physiology, University of Tennessee, Memphis, Tennessee (G.T.) This paper is available online at http://pharmrev.aspetjournals.org Abstract ............................................................................... 265 I. Introduction............................................................................ 265 II. Discovery of lysophospholipid receptors ................................................... 266 III. Receptor nomenclature ................................................................. -
Dissociation of Inositol Trisphosphate from Diacylglycerol Production in Rous Sarcoma Virus-Transformed Fibroblasts Timothy J
Dissociation of Inositol Trisphosphate from Diacylglycerol Production in Rous Sarcoma Virus-transformed Fibroblasts Timothy J. Martins, Yoshikazu Sugimoto, and R. L. Erikson Department of Cellular and Developmental Biology, Harvard University, Cambridge, Massachusetts 02138 Abstract. The metabolism of phosphatidylinositol (PI) changes intermediate between those of transformed and and related intermediates was studied in uninfected nontransformed cells. NY72-4 CEF exhibited no in- and Rous sarcoma virus-(RSV) infected chicken em- crease in phosphoinositol concentrations before 8 h in- bryo fibroblasts (CEFs). Cells infected with wild-type cubation at 35°C, indicating that the transformation- Downloaded from http://rupress.org/jcb/article-pdf/108/2/683/1057290/683.pdf by guest on 26 September 2021 RSV exhibited twofold increases in steady-state con- specific changes in inositol metabolism were a delayed centrations of inositol trisphosphate (IP3) and inositol event. Furthermore, inositol turnover was not activated bisphosphate (IP2) as compared to uninfected CEFs. In during this time. In contrast to the case of inositol me- addition, increased concentrations of IP3 and IP2 were tabolism, significant increases in diacylglycerol (DAG) observed in CEFs infected with the RSV temperature- concentrations were observed within 15-30 min after sensitive transformation mutant NY72-4 when main- shift of NY72-4 CEFs to 35°C. tained at the permissive temperature (35°C) for >24 h. These findings suggest that (a) the major changes in Slight increases were -
Regulation of Signaling and Metabolism by Lipin-Mediated Phosphatidic Acid Phosphohydrolase Activity
biomolecules Review Regulation of Signaling and Metabolism by Lipin-mediated Phosphatidic Acid Phosphohydrolase Activity Andrew J. Lutkewitte and Brian N. Finck * Center for Human Nutrition, Division of Geriatrics and Nutritional Sciences, Department of Medicine, Washington University School of Medicine, Euclid Avenue, Campus Box 8031, St. Louis, MO 63110, USA; [email protected] * Correspondence: bfi[email protected]; Tel: +1-3143628963 Received: 4 September 2020; Accepted: 24 September 2020; Published: 29 September 2020 Abstract: Phosphatidic acid (PA) is a glycerophospholipid intermediate in the triglyceride synthesis pathway that has incredibly important structural functions as a component of cell membranes and dynamic effects on intracellular and intercellular signaling pathways. Although there are many pathways to synthesize and degrade PA, a family of PA phosphohydrolases (lipin family proteins) that generate diacylglycerol constitute the primary pathway for PA incorporation into triglycerides. Previously, it was believed that the pool of PA used to synthesize triglyceride was distinct, compartmentalized, and did not widely intersect with signaling pathways. However, we now know that modulating the activity of lipin 1 has profound effects on signaling in a variety of cell types. Indeed, in most tissues except adipose tissue, lipin-mediated PA phosphohydrolase activity is far from limiting for normal rates of triglyceride synthesis, but rather impacts critical signaling cascades that control cellular homeostasis. In this review, we will discuss how lipin-mediated control of PA concentrations regulates metabolism and signaling in mammalian organisms. Keywords: phosphatidic acid; diacylglycerol; lipin; signaling 1. Introduction Foundational work many decades ago by the laboratory of Dr. Eugene Kennedy defined the four sequential enzymatic steps by which three fatty acyl groups were esterified onto the glycerol-3-phosphate backbone to synthesize triglyceride [1]. -
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
International Journal of Neuropsychopharmacology Advance Access published March 3, 2015 International Journal of Neuropsychopharmacology, 2015, 1–14 doi:10.1093/ijnp/pyu111 Research Article research article Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats Aline Sayd, MSc; María Antón, MSc; Francisco Alén, PhD; Javier Rubén Caso, Downloaded from PhD; Javier Pavón, PhD; Juan Carlos Leza, MD, PhD; Fernando Rodríguez de Fonseca, MD, PhD; Borja García-Bueno, PhD; Laura Orio PhD Department of Psychobiology, Faculty of Psychology, Complutense University, Complutense University of Madrid http://ijnp.oxfordjournals.org/ (UCM), Madrid, Spain (Ms Antón, and Drs Alén, Rodríguez de Fonseca and Orio); Department of Pharmacology, Faculty of Medicine, UCM, and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)), Madrid, Spain (Ms Sayd, and Drs Leza and García-Bueno); Department of Psychiatry, Faculty of Medicine, UCM, and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain (Dr Caso); UGC Salud Mental, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga-Universidad de Málaga, and Red de Trastornos Adictivos, Málaga, Spain (Drs Pavón and Rodríguez de Fonseca). A.S., M.A., B.G.-B., and L.O. contributed equally to this work. by guest on April 29, 2016 Correspondence: Laura Orio, PhD, Department of Psychobiology, Faculty of Psychology, Complutense University of Madrid, Campus de Somosaguas s/n, 28223 Pozuelo de Alarcón, Madrid (email: [email protected].); and Borja García-Bueno, PhD, Department of Pharmacology, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, 28480 Madrid, Spain ([email protected]). Abstract Background: The acylethanolamides oleoylethanolamide and palmitoylethanolamide are endogenous lipid mediators with proposed neuroprotectant properties in central nervous system (CNS) pathologies.